Half of Gen Z with Depression Report Regular Cannabis Use, Study Finds

A survey commissioned by precision psychiatry company NeuroKaire reveals that 50% of Generation Z individuals diagnosed with depression report using cannabis regularly or occasionally. This significant finding highlights a growing trend among young adults self-managing mental health symptoms through cannabinoid use. The data underscores the need for clinical research on cannabis efficacy for depression treatment and informed discussions between patients and healthcare providers. Mental health professionals emphasize the importance of evidence-based approaches and monitoring potential interactions with conventional antidepressant therapies. This survey provides valuable insights into cannabis consumption patterns among younger demographics seeking mental health relief.